放射治疗中线恶网50例总结

RADIATION THERAPY OF MIDLINE MALIGNANT RETICULOSIS Report on 50 patients

我院从1959年6月至1981年12月共收治中线恶网(MMR)50例,均经病理证实并四次复检确认。长期随访,失随1例按死亡计。本文旨在总结放射治疗中线恶网的效果,并探讨影响预后的因素。

Midline malignant reticulosis (MMR) is a lymphoreticular system disease. Fifty patients with MMR were treated from 1959 to 1981 with radiotherapy in our hospital.All patients were proved by pathology and followed for over 5 years. The 2 and 5 year survival rates were 52%(26/50)and44%(22/50).Dose of 40-55 Gy/4-5.5 wk was considered to be optimal for the control of this disease. If enlarged regional lymph nodes were present, they should be treated. If not, radiotherapy could be withheld. The microscopic features of these lesions were consistent with the peripheral T-cell lymphoma (PTL). Monomorphism, if present, implies poor prognosis.